FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Alessandra Rubagotti

Research Profile

Procedures

Antineoplastic Combined Chemotherapy Protocols

Chemicals & Drugs

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
Francesca Argellati; Rosa Mangerini; Pier Vitale Nuzzo; Francesco Ricci; Alessandra Rubagotti; Francesco Boccardo
Dihydrotestosterone and bicalutamide do not affect Periostin expression in androgen-dependent LNCaP prostate cancer cell lines.
Francesco Ricci; Alessandra Rubagotti; Alchiede Simonato; Linda Zinoli; Cecilia Balbi; Paola Barboro; Giorgio Carmignani; Rosa Mangerini; Pier Vitale Nuzzo; Francesco Boccardo
Prognostic value of nuclear matrix protein expression in localized prostate cancer.
Pamela Guglielmini; Alessandra Rubagotti; Francesco Boccardo
Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Alessandra Rubagotti (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Francesca Argellati; Rosa Mangerini; Pier Vitale Nuzzo; Francesco Ricci; Alessandra Rubagotti; Francesco Boccardo
Dihydrotestosterone and bicalutamide do not affect Periostin expression in androgen-dependent LNCaP prostate cancer cell lines.
Anticancer research 2013;33(3):815-20.
2012: Francesco Ricci; Alessandra Rubagotti; Alchiede Simonato; Linda Zinoli; Cecilia Balbi; Paola Barboro; Giorgio Carmignani; Rosa Mangerini; Pier Vitale Nuzzo; Francesco Boccardo
Prognostic value of nuclear matrix protein expression in localized prostate cancer.
Journal of cancer research and clinical oncology 2012;138(8):1379-84.
2012: Pamela Guglielmini; Alessandra Rubagotti; Francesco Boccardo
Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study.
Breast cancer research and treatment 2012;132(2):661-8.
2012: Pier Vitale Nuzzo; Francesco Ricci; Alessandra Rubagotti; Sandra Salvi; Linda Zinoli; Simona Boccardo; Francesco Boccardo
Prognostic value of stromal and epithelial periostin expression in human prostate cancer: correlation with clinical pathological features and the risk of biochemical relapse or death.
BMC cancer 2012;12():625.
2011: Paola Barboro; Francesco Boccardo; Nicoletta Ferrari; Erica Repaci; Alessandra Rubagotti; Cecilia Balbi
Androgen receptor and heterogeneous nuclear ribonucleoprotein K colocalize in the nucleoplasm and are modulated by bicalutamide and 4-hydroxy-tamoxifen in prostatic cancer cell lines.
The Prostate 2011;71(13):1466-79.
2011: Francesco Boccardo; Pamela Guglielmini; Andrea Parodi; Alessandra Rubagotti
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen receptor-positive breast cancer patients. Very late results of the 'gruppo di ricerca per la chemio-ormonoterapia adiuvante (GROCTA)' 01-Trial in early breast cancer.
Breast cancer research and treatment 2011;126(3):653-61.
2010: Davide Bedognetti; Alessandra Rubagotti; Giario Conti; Francesco Francesca; Ottavio De Cobelli; Luca Canclini; Michele Gallucci; Francesco Aragona; Pasquale Di Tonno; Pietro Cortellini; Giuseppe Martorana; Alberto Lapini; Francesco Boccardo
An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients.
European urology 2010;57(2):238-45.
2010: Francesco Boccardo; Dino Amadori; Pamela Guglielmini; Piero Sismondi; Antonio Farris; Biagio Agostara; Angelo Gambi; Giuseppina Catalano; Marina Faedi; Alessandra Rubagotti
Epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil versus paclitaxel followed by epirubicin and vinorelbine in patients with high-risk operable breast cancer.
Oncology 2010;78(3-4):274-81.
2010: Davide Bedognetti; Alessandra Rubagotti; Gabriele Zoppoli; Francesco Boccardo
Gynaecomastia: the anastrozole paradox.
Journal of pediatric endocrinology & metabolism : JPEM 2010;23(1-2):205-6.
2009: Paola Barboro; E Repaci; Alessandra Rubagotti; S Salvi; S Boccardo; B Spina; Mauro Truini; C Introini; Paolo Puppo; N Ferrari; Giorgio Carmignani; Francesco Boccardo; Cecilia Balbi
Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer.
British journal of cancer 2009;100(10):1608-16.
2008: Francesco Boccardo; Alessandra Rubagotti; Giario Conti; Michele Battaglia; Giorgio Cruciani; Antonio Manganelli; Sergio Ricci; Alberto Lapini
Prednisone plus gefitinib versus prednisone plus placebo in the treatment of hormone-refractory prostate cancer: a randomized phase II trial.
Oncology 2008;74(3-4):223-8.
2008: Paola Barboro; Alessandra Rubagotti; Paola Orecchia; Bruno Spina; Mauro Truini; Erica Repaci; Giorgio Carmignani; Andrea Romagnoli; Carlo Introini; Francesco Boccardo; Barbara Carnemolla; Cecilia Balbi
Differential proteomic analysis of nuclear matrix in muscle-invasive bladder cancer: potential to improve diagnosis and prognosis.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2008;30(1):13-26.
2007: Francesco Boccardo; Alessandra Rubagotti; Daniela Aldrighetti; Franco Buzzi; Giorgio Cruciani; Antonio Farris; Giorgio Mustacchi; Mauro Porpiglia; Giorgio Schieppati; Piero Sismondi
Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma: pooled analysis of 2 consecutive trials.
Cancer 2007;109(6):1060-7.
2007: Francesco Boccardo; Alessandra Rubagotti
Switching to aromatase inhibitors in early breast cancer.
Lancet 2007;369(9561):533-5.
2006: Walter Jonat; Michael Gnant; Francesco Boccardo; Manfred Kaufmann; Alessandra Rubagotti; Ivan Zuna; Mike Greenwood; Raimund Jakesz
Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: a meta-analysis.
The lancet oncology 2006;7(12):991-6.
2006: Fabia Galmozzi; Alessandra Rubagotti; Andrea Romagnoli; Giorgio Carmignani; Luisa Perdelli; Beatrice Gatteschi; Francesco Boccardo
Prognostic value of cell cycle regulatory proteins in muscle-infiltrating bladder cancer.
Journal of cancer research and clinical oncology 2006;132(12):757-64.
2006: Francesco Boccardo; Alessandra Rubagotti; Pamela Guglielmini; A Fini; G Paladini; Mario Mesiti; Michela Rinaldini; S Scali; Mauro Porpiglia; C Benedetto; N Restuccia; Franco Buzzi; R Franchi; Bruno Massidda; Vito Distante; Dino Amadori; Piero Sismondi
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 7():vii10-4.
2006: Francesco Boccardo; Alessandra Rubagotti; Michele Battaglia; Filiberto Zattoni; Alessandro Bertaccini; Andrea Romagnoli; Giario Conti
Influence of bicalutamide with or without tamoxifen or anastrozole on insulin-like growth factor 1 and binding proteins in prostate cancer patients.
The International journal of biological markers 2006;21(2):123-6.
2006: Rosella Coradeghini; Paola Barboro; Alessandra Rubagotti; Francesco Boccardo; Stefano Parodi; Giorgio Carmignani; Cristina D'Arrigo; Eligio Patrone; Cecilia Balbi
Differential expression of nuclear lamins in normal and cancerous prostate tissues.
Oncology reports 2006;15(3):609-13.
2006: Francesco Boccardo; Matteo Puntoni; Pamela Guglielmini; Alessandra Rubagotti
Enterolactone as a risk factor for breast cancer: a review of the published evidence.
Clinica chimica acta; international journal of clinical chemistry 2006;365(1-2):58-67.
2005: Attilio Olivieri; Gino Santini; Caterina Patti; Teodoro Chisesi; C De Souza; Alessandra Rubagotti; Savina Aversa; Atto Billio; Adolfo Porcellini; Marco Candela; Riccardo Centurioni; Angela Congiu; Marino Brunori; Sandro Nati; Mauro Spriano; Renato Vimercati; Gennaro Marino; Antonio Contu; L Tedeschi; Ignazio Majolino; monica crugnola; Mario Roberto Sertoli
Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSG.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(12):1941-8.
2005: Paola Barboro; Alessandra Rubagotti; Francesco Boccardo; Barbara Carnemolla; Cristina Darrigo; Eligio Patrone; Cecilia Balbi
Nuclear matrix protein expression in prostate cancer: possible prognostic and diagnostic applications.
Anticancer research 2005;25(6B):3999-4004.
2005: Francesco Boccardo; Alessandra Rubagotti; Giario Conti; Domenico Potenzoni; Antonio Manganelli; Demetrio Del Monaco
Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer.
Cancer chemotherapy and pharmacology 2005;56(4):415-20.
2005: Francesco Boccardo; Alessandra Rubagotti; Matteo Puntoni; Pamela Guglielmini; Domenico Amoroso; Angela Fini; Giuseppe Paladini; Mario Mesiti; Domenico Romeo; Michela Rinaldini; Simona Scali; Mauro Porpiglia; Chiara Benedetto; Nunzio Restuccia; Franco Buzzi; Roberto Franchi; Bruno Massidda; Vito Distante; Dino Amadori; Piero Sismondi
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):5138-47.
2005: Francesco Boccardo; Alessandra Rubagotti; Michele Battaglia; Pasquale Di Tonno; FP Selvaggi; Giario Conti; Giancarlo Comeri; Alessandro Bertaccini; Giuseppe Martorana; P Galassi; Filiberto Zattoni; A Macchiarella; A Siragusa; G Muscas; F Durand; Domenico Potenzoni; Antonio Manganelli; Valentino Ferraris; Franco Montefiore
Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(4):808-15.
2005: Elena Verri; Pamela Guglielmini; Matteo Puntoni; Luisa Perdelli; Andrea Papadia; Paola Lorenzi; Alessandra Rubagotti; Nicola Ragni; Francesco Boccardo
HER2/neu oncoprotein overexpression in epithelial ovarian cancer: evaluation of its prevalence and prognostic significance. Clinical study.
Oncology 2005;68(2-3):154-61.
2004: Gino Santini; Teodoro Chisesi; Sandro Nati; Adolfo Porcellini; Valerio Zoli; Vittorio Rizzoli; Simona Zupo; Gennaro Marino; Alessandra Rubagotti; Alessandro Polacco; Mauro Spriano; Renato Vimercati; Angela Congiu; Jean Louis Ravetti; Savina Aversa; Marco Candela; Caterina Patti
Fludarabine, cyclophosphamide and mitoxantrone for untreated follicular lymphoma: a report from the non-Hodgkin's lymphoma co-operative study group.
Leukemia & lymphoma 2004;45(6):1141-7.
2004: Gino Santini; C De Souza; Savina Aversa; Caterina Patti; L Tedeschi; Marco Candela; Attilio Olivieri; Teodoro Chisesi; Alessandra Rubagotti; Riccardo Centurioni; V Nardi; M Congiu; M Gennaro; Mauro Truini
A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma: report from the Italian Non-Hodgkin's Lymphoma Co-operative Study Group.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica ... [et al.] 2004;37(5):719-28.
2004: Francesco Boccardo; G Lunardi; Pamela Guglielmini; M Parodi; R Murialdo; G Schettini; Alessandra Rubagotti
Serum enterolactone levels and the risk of breast cancer in women with palpable cysts.
European journal of cancer (Oxford, England : 1990) 2004;40(1):84-9.
2003: Francesco Boccardo; Alessandra Rubagotti; Giorgio Carmignani; Andrea Romagnoli; Guido Nicolò; Paola Barboro; Stefano Parodi; Eligio Patrone; Cecilia Balbi
Nuclear matrix proteins changes in cancerous prostate tissues and their prognostic value in clinically localized prostate cancer.
The Prostate 2003;55(4):259-64.
2003: Francesco Boccardo; Gian Luigi Lunardi; Anna Rita Petti; Alessandra Rubagotti
Enterolactone in breast cyst fluid: correlation with EGF and breast cancer risk.
Breast cancer research and treatment 2003;79(1):17-23.
2002: Francesco Boccardo; Mario Barichello; Michele Battaglia; Giorgio Carmignani; Giancarlo Comeri; Valentino Ferraris; Sergio Lilliu; Franco Montefiore; Filippo Portoghese; Pietro Cortellini; Patrizio Rigatti; Enzo Usai; Alessandra Rubagotti
Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer: updated results of a multicentric trial.
European urology 2002;42(5):481-90.
2002: Elio Geido; Andrea Sciutto; Alessandra Rubagotti; Cristina Oliani; Roberto Monaco; Mauro Risio; Walter Giaretti
Combined DNA flow cytometry and sorting with k-ras2 mutation spectrum analysis and the prognosis of human sporadic colorectal cancer.
Cytometry 2002;50(4):216-24.
2001: Francesco Boccardo; Alessandra Rubagotti; Domenico Amoroso; Mario Mesiti; Domenico Romeo; C Caroti; Antonio Farris; Giorgio Cruciani; E Villa; Giorgio Schieppati; Giorgio Mustacchi
Sequential tamoxifen and aminoglutethimide versus tamoxifen alone in the adjuvant treatment of postmenopausal breast cancer patients: results of an Italian cooperative study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(22):4209-15.
2001: Francesco Boccardo; Loredana Miglietta; Milena Bruzzone; Alessandra Rubagotti; M C Locatelli; N Ragni
Paclitaxel plus organoplatins: still the gold standard in advanced ovarian cancer?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(7):1023-4.
2001: Gino Santini; Sandro Nati; Mauro Spriano; Andrea Gallamini; D Pierluigi; Angela Congiu; Mauro Truini; Alessandra Rubagotti; Teodoro Chisesi; Renato Vimercati; Edoardo Rossi; Mario Roberto Sertoli; Daniele Mattei; Gennaro Marino; marco gobbi
Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma.
Haematologica 2001;86(3):282-6.
2001: Alberto Ballestrero; Alessandra Rubagotti; P Stura; Fabio Ferrando; Domenico Amoroso; Michela Rinaldini; Piero Sismondi; Franco Genta; Mario Mesiti; Fulvio Brema; Franco Patrone; Francesco Boccardo
Adjuvant chemotherapy with high-dose cyclophosphamide, etoposide and cisplatin intensification without progenitor cell support in breast cancer patients with ten or more involved nodes: 5-year results of a pilot trial.
Oncology 2001;60(3):221-7.
2000: Francesco Boccardo; Alessandra Rubagotti; Domenico Amoroso; Mario Mesiti; Domenico Romeo; Piero Sismondi; Maurizia Giai; Franco Genta; P Pacini; Vito Distante; A Bolognesi; Daniela Aldrighetti; Antonio Farris
Cyclophosphamide, methotrexate, and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-/perimenopausal breast cancer patients: results of the Italian Breast Cancer Adjuvant Study Group 02 randomized trial. boccardo@hp380.ist.unige.it.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(14):2718-27.
2000: Gino Santini; Paolo Coser; Angela Congiu; L Salvagno; C De Souza; Mario Roberto Sertoli; Attilio Olivieri; Teodoro Chisesi; Alessandra Rubagotti; Mauro Truini; Antonio Contu; Adolfo Porcellini; G Zambaldi; Sandro Nati; Gennaro Marino; Vittorio Rizzoli
VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group.
Haematologica 2000;85(2):160-6.
1999: Francesco Boccardo; Alessandra Rubagotti; M Barichello; Michele Battaglia; Giorgio Carmignani; Giancarlo Comeri; Giario Conti; Giorgio Cruciani; S Dammino; U Delliponti; P Ditonno; Valentino Ferraris; S Lilliu; Franco Montefiore; F Portoghese; G Spano
Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: results of an Italian Prostate Cancer Project study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(7):2027-38.
1999: Gino Santini; C De Souza; Angela Congiu; Sandro Nati; Gennaro Marino; Monica Soracco; Mario Roberto Sertoli; Alessandra Rubagotti; Mauro Spriano; F Vassallo; Edoardo Rossi; Renato Vimercati; Giovanna Piaggio; Osvaldo Figari; Federica Benvenuto; M Abate; Mauro Truini; Jean Louis Ravetti; I Ribizzi; Eugenio E Damasio
High-dose cyclophosphamide followed by autografting can improve the outcome of relapsed or resistant non-Hodgkin's lymphomas with involved or hypoplastic bone marrow.
Leukemia & lymphoma 1999;33(3-4):321-30.
1999: Angelo Michele Carella; Enrica Lerma; Maria T Corsetti; AM Dejana; P Basta; F Vassallo; M Abate; Monica Soracco; Federica Benvenuto; Osvaldo Figari; M Podestá; Giovanna Piaggio; R Ferrara; Mario Sessarego; C Parodi; M Pizzuti; Alessandra Rubagotti; Domenico Occhini; Francesco Frassoni
Autografting with philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia.
Blood 1999;93(5):1534-9.
1999: Francesco Boccardo; Alessandra Rubagotti; Domenico Amoroso; Biagio Agostara; Dino Amadori; L Gallo; Stefano Iacobelli; Bruno Massidda; Mario Mesiti; P Pacini; Silverio Tomao; Michela Paganuzzi; Paola Marroni
Endocrinological and clinical evaluation of two depot formulations of leuprolide acetate in pre- and perimenopausal breast cancer patients.
Cancer chemotherapy and pharmacology 1999;43(6):461-6.
1998: Gino Santini; L Salvagno; Pietro Leoni; Teodoro Chisesi; C De Souza; Mario Roberto Sertoli; Alessandra Rubagotti; Angela Congiu; Riccardo Centurioni; Attilio Olivieri; L Tedeschi; M Vespignani; Sandro Nati; Monica Soracco; Adolfo Porcellini; Antonio Contu; C Guarnaccia; N Pescosta; Ignazio Majolino; Mauro Spriano; Renato Vimercati; Edoardo Rossi; G Zambaldi; Lina Mangoni; Vittorio Rizzoli
VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2796-802.
1998: Francesco Boccardo; Alessandra Rubagotti; Domenico Amoroso; Mario Mesiti; P Pacini; L Gallo; Piero Sismondi; Maurizia Giai; Franco Genta; Giorgio Mustacchi; Biagio Agostara; A Bolognesi; E Villa; Giorgio Schieppati; G P Ausili Cefaro; R Bellantone; Antonio Farris; M Sassi; Franco Patrone
Italian Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group Trials. GROCTA Trials.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1998;152():453-70.
1997: Editta Baldini; Giovanni Gardin; Piergiorgio Giannessi; Fulvio Brema; A Camorriano; Flavio Carnino; C Naso; G Pastorino; Paolo Pronzato; Riccardo Rosso; Alessandra Rubagotti; G Torretta; Pier Franco Conte
A randomized trial of chemotherapy with or without estrogenic recruitment in locally advanced breast cancer. North-West Oncology Group (GONO) Study, Italy.
Tumori 1997;83(5):829-33.
1997: Milena Bruzzone; Alessandra Rubagotti; Angiolo Gadducci; E Catsafados; Giovanni Foglia; Isa Maura Brunetti; Piergiorgio Giannessi; Flavio Carnino; L Iskra; R Rosso; Andrea Martoni; F Pannuti; V De Lisi; Roberta Maltoni; Ruggero Ridolfi; Serafina Mammoliti; L Gallo; Francesco Boccardo; Nicola Ragni; Pier Franco Conte
Intraperitoneal carboplatin with or without interferon-alpha in advanced ovarian cancer patients with minimal residual disease at second look: a prospective randomized trial of 111 patients. G.O.N.O. Gruppo Oncologic Nord Ovest.
Gynecologic oncology 1997;65(3):499-505.
1997: Francesco Boccardo; Alessandra Rubagotti; Domenico Amoroso; A Perrotta; Piero Sismondi; Antonio Farris; Mario Mesiti; L Gallo; P Pacini; E Villa; Biagio Agostara
Lack of effectiveness of adjuvant alternating chemotherapy in node-positive, estrogen-receptor-negative premenopausal breast cancer patients: results of a multicentric Italian study. The Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group (GROCTA).
Cancer investigation 1997;15(6):505-12.
1996: Pier Franco Conte; Editta Baldini; Giovanni Gardin; Paolo Pronzato; D Amadori; Flavio Carnino; C Monzeglio; P Gentilini; P Gallotti; R DeMicheli; Marco Venturini; Alessandra Rubagotti; R Rosso
Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(5):487-90.
1996: Alessandra Rubagotti; A Perrotta; Claudia Casella; Francesco Boccardo
Risk of new primaries after chemotherapy and/or tamoxifen treatment for early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(3):239-44.
1996: Pier Franco Conte; Milena Bruzzone; Flavio Carnino; Angiolo Gadducci; R Algeri; A Bellini; Francesco Boccardo; Isa Maura Brunetti; E Catsafados; Silvana Chiara; Giovanni Foglia; L Gallo; L Iskra; Serafina Mammoliti; G Parodi; Nicola Ragni; R Rosso; S Rugiati; Alessandra Rubagotti
High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):351-6.
1995: Francesco Boccardo; M Pace; A Perrotta; Alessandra Rubagotti
[Medical therapy of locally advanced prostatic neoplasms].
Minerva urologica e nefrologica = The Italian journal of urology and nephrology 1995;47(4):203-8.
1995: L Canobbio; Alessandra Rubagotti; Loredana Miglietta; D Cannata; A Curotto; Domenico Amoroso; Francesco Boccardo
Prognostic factors for survival in patients with advanced renal cell carcinoma treated with interleukin-2 and interferon-alpha.
Journal of cancer research and clinical oncology 1995;121(12):753-6.
1994: E Campora; S Giudici; L Merlini; Alessandra Rubagotti; R Rosso
Ondansetron and dexamethasone versus standard combination antiemetic therapy. A randomized trial for the prevention of acute and delayed emesis induced by cyclophosphamide-doxorubicin chemotherapy and maintenance of antiemetic effect at subsequent courses.
American journal of clinical oncology 1994;17(6):522-6.
1994: Mario Roberto Sertoli; Gino Santini; Teodoro Chisesi; Angela Congiu; Alessandra Rubagotti; A Contu; Luigi Salvagno; Paolo Coser; A Porcellini; M Vespignani
MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(7):1366-74.
1994: Francesco Boccardo; Alessandra Rubagotti; A Perrotta; Domenico Amoroso; M Balestrero; A De Matteis; P Zola; Piero Sismondi; G Francini; R Petrioli
Ovarian ablation versus goserelin with or without tamoxifen in pre-perimenopausal patients with advanced breast cancer: results of a multicentric Italian study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(4):337-42.
1994: Silvana Chiara; P Conte; Paola Franzone; M Orsatti; Milena Bruzzone; Alessandra Rubagotti; F Odicino; S Rugiati; Flavio Carnino; R Rosso
High-risk early-stage ovarian cancer. Randomized clinical trial comparing cisplatin plus cyclophosphamide versus whole abdominal radiotherapy.
American journal of clinical oncology 1994;17(1):72-6.
1994: Francesco Boccardo; D Cannata; Alessandra Rubagotti; D Guarneri; Andrea Decensi; L Canobbio; A Curotto; G Martorana; C Pegoraro; F Selvaggi
Prophylaxis of superficial bladder cancer with mitomycin or interferon alfa-2b: results of a multicentric Italian study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(1):7-13.
1993: Paolo Pronzato; Alessandra Rubagotti; Domenico Amoroso; Gianfilippo Bertelli; Paola Queirolo; Mario Roberto Sertoli; M Rosso; P Gallotti; C Monzeglio; R Rosso
Second-line hormonotherapy for breast cancer. Uselessness of first-line continuation.
American journal of clinical oncology 1993;16(6):522-5.
1993: Editta Baldini; Giovanni Gardin; C Naso; Paolo Pronzato; R Rosso; Alessandra Rubagotti; C Monzeglio; Fulvio Brema; G Pastorino; D Amadori
Stimulation of human breast cancer in vivo. Experimental findings and clinical results.
Annals of the New York Academy of Sciences 1993;698():418-22.
1993: Francesco Boccardo; Domenico Amoroso; Alessandra Rubagotti; Piero Sismondi; C De Sanctis; M Cappellini; P Pacini; Luigi Castagnetta; Adele Traina; Antonio Farris
Endocrine therapy of breast cancer. The experience of the Italian Cooperative Group for Chemohormonal Therapy of Early Breast Cancer (GROCTA).
Annals of the New York Academy of Sciences 1993;698():318-29.
1993: Andrea Ardizzoni; F Salvati; R Rosso; Paolo Bruzzi; Alessandra Rubagotti; MC Pennucci; G L Mariani; Filippo De Marinis; G Pallotta; Antonio Antilli
Combination of chemotherapy and recombinant alpha-interferon in advanced non-small cell lung cancer. Multicentric Randomized FONICAP Trial Report. The Italian Lung Cancer Task Force.
Cancer 1993;72(10):2929-35.
1993: Paolo Pronzato; Gianfilippo Bertelli; Giovanni Gardin; Alessandra Rubagotti; Pier Franco Conte; R Rosso
Analysis of time to response to chemotherapy in 316 metastatic breast cancer patients.
Oncology 1993;50(6):460-5.
1993: Milena Bruzzone; E Campora; Silvana Chiara; S Giudici; L Merlini; C Simoni; Serafina Mammoliti; Alessandra Rubagotti; R Rosso
Cerebral metastases secondary to ovarian cancer: still an unusual event.
Gynecologic oncology 1993;49(1):37-40.
1993: Paolo Pronzato; Loredana Miglietta; Alessandra Rubagotti; Gianfilippo Bertelli; Paola Queirolo; M Guenzi; Mario Roberto Sertoli; Vito Vitale; R Rosso
Impact of irradiation of residual breast on adjuvant chemotherapy dose intensity.
American journal of clinical oncology 1993;16(1):58-60.
1993: Francesco Boccardo; M Pace; Alessandra Rubagotti; D Guarneri; Andrea Decensi; Francesco Oneto; G Martorana; L Giuliani; F Selvaggi; M Battaglia
Goserelin acetate with or without flutamide in the treatment of patients with locally advanced or metastatic prostate cancer. The Italian Prostatic Cancer Project (PONCAP) Study Group.
European journal of cancer (Oxford, England : 1990) 1993;29A(8):1088-93.
1993: Lazzaro Repetto; M Pace; Serafina Mammoliti; Milena Bruzzone; Silvana Chiara; C Oliva; T Guido; Pier Franco Conte; E Campora; Alessandra Rubagotti
The impact of received dose intensity on the outcome of advanced ovarian cancer.
European journal of cancer (Oxford, England : 1990) 1993;29A(2):181-4.
1992: Francesco Boccardo; Alessandra Rubagotti; Domenico Amoroso; Piero Sismondi; Franco Genta; Italo Nenci; A Piffanelli; Antonio Farris; Luigi Castagnetta; Adele Traina
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st GROCTA (Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group) trial.
European journal of cancer (Oxford, England : 1990) 1992;28(2-3):673-80.
1992: Maria Teresa Nobile; R Rosso; Mario Roberto Sertoli; Alessandra Rubagotti; M G Vidili; A Guglielmi; Marco Venturini; L Canobbio; T Fassio; L Gallo
Randomised comparison of weekly bolus 5-fluorouracil with or without leucovorin in metastatic colorectal carcinoma.
European journal of cancer (Oxford, England : 1990) 1992;28A(11):1823-7.
1990: E Campora; Editta Baldini; Alessandra Rubagotti; Silvana Chiara; Paolo Bruzzi; Mario Roberto Sertoli; R Rosso
Double-blind randomized trial of lorazepam versus placebo with methylprednisolone for control of emesis due to non-cisplatin containing chemotherapy.
Journal of chemotherapy (Florence, Italy) 1990;2(5):336-9.
1990: Milena Bruzzone; Lazzaro Repetto; Silvana Chiara; E Campora; Pier Franco Conte; M Orsatti; Vito Vitale; Alessandra Rubagotti; R Rosso
Chemotherapy versus radiotherapy in the management of ovarian cancer patients with pathological complete response or minimal residual disease at second look.
Gynecologic oncology 1990;38(3):392-5.
1990: Francesco Boccardo; Alessandra Rubagotti; Paolo Bruzzi; M Cappellini; G Isola; Italo Nenci; A Piffanelli; A Scanni; Piero Sismondi; L Santi
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(8):1310-20.
1990: R Rosso; F Salvati; Andrea Ardizzoni; C Gallo Curcio; Alessandra Rubagotti; M Belli; Bruno Castagneto; V Fusco; M Sassi; G Ferrara
Etoposide versus etoposide plus high-dose cisplatin in the management of advanced non-small cell lung cancer. Results of a prospective randomized FONICAP trial. Italian Lung Cancer Task Force.
Cancer 1990;66(1):130-4.
1990: Francesco Boccardo; Andrea Decensi; D Guarneri; Alessandra Rubagotti; Francesco Oneto; G Martorana; L Giuliani; U Delli Ponti; S Petracco; P Cortellini
Zoladex with or without flutamide in the treatment of locally advanced or metastatic prostate cancer: interim analysis of an ongoing PONCAP study. Italian Prostatic Cancer Project (PONCAP).
European urology 1990;18 Suppl 3():48-53.
1989: Pier Franco Conte; Angela Alama; Alessandra Rubagotti; Silvana Chiara; Annamaria Bevilacqua; R Rosso; M Gaddi; B Ghiringhello; Silverio Tomao
Cell kinetics in ovarian cancer. Relationship to clinicopathologic features, responsiveness to chemotherapy, and survival.
Cancer 1989;64(6):1188-91.
1988: Maria Teresa Nobile; L Canobbio; Alberto Sobrero; Enzo Galligioni; M G Vidili; T Fassio; G Lo Re; Alessandra Rubagotti; Mario Roberto Sertoli; R Rosso
A randomized trial of 5-fluorouracil alone versus 5-fluorouracil and high dose leucovorin in untreated advanced colorectal cancer patients.
Advances in experimental medicine and biology 1988;244():213-8.
1988: Francesco Boccardo; Andrea Decensi; D Guarneri; Alessandra Rubagotti; G Martorana; Claudio Giberti; G B Cerruti; F Tani; A Zanollo; T Germinale
Long-acting (depot) D-TRP-6 LH-RH (Decapeptyl) in prostate cancer. An Italian multicentric trial.
American journal of clinical oncology 1988;11 Suppl 2():S129-31.
1987: Pier Franco Conte; Alessandra Rubagotti; Alfredo Falcone; Giovanni Gardin; Annamaria Bevilacqua; Paolo Pronzato; R Rosso; D Amadori; P Gentilini; Piero Sismondi
Cytokinetic-based versus conventional chemotherapy in metastatic breast cancer: a randomized study.
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy 1987;6(2 Suppl):712-3.
1987: Pier Franco Conte; Paolo Pronzato; Alessandra Rubagotti; Angela Alama; D Amadori; R Demicheli; Giovanni Gardin; P Gentilini; A Jacomuzzi; Rita Lionetto
Conventional versus cytokinetic polychemotherapy with estrogenic recruitment in metastatic breast cancer: results of a randomized cooperative trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(3):339-47.
1987: Mario Roberto Sertoli; D Guarneri; Alessandra Rubagotti; G Porcile; M T Nobile; R Rosso
Adjuvant immunochemotherapy in colorectal cancer Dukes C.
Oncology 1987;44(2):78-81.
1987: Francesco Boccardo; Andrea Decensi; D Guarneri; Alessandra Rubagotti; T Massa; G Martorana; Claudio Giberti; G B Cerruti; F Tani; A Zanollo
Long-term results with a long-acting formulation of D-TRP-6 LH-RH in patients with prostate cancer: an Italian prostatic cancer project (P.O.N.CA.P.) study.
The Prostate 1987;11(3):243-55.
1986: Pier Franco Conte; Milena Bruzzone; Silvana Chiara; Mario Roberto Sertoli; M G Daga; Alessandra Rubagotti; A Conio; M Ruvolo; R Rosso; L Santi
A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(6):965-71.
1985: Pier Franco Conte; M R Sertoli; Milena Bruzzone; Alessandra Rubagotti; R Rosso; G Bentivoglio; A Conio; G Pescetto
Cisplatin, methotrexate, and 5-fluorouracil combination chemotherapy for advanced ovarian cancer.
Gynecologic oncology 1985;20(3):290-7.
1984: Francesco Boccardo; D Guarneri; Alessandra Rubagotti; G L Casertelli; G Bentivoglio; N Conte; G Campanella; G Gaggero; G Comelli; S Zanardi
Endocrine effects of tamoxifen in postmenopausal breast cancer patients.
Tumori 1984;70(1):61-8.
1982: R Rosso; M T Nobile; Fulvio Brema; G Porcile; A Cinquegrana; M De Palma; Alessandra Rubagotti
Randomized trial of chemoimmunotherapy in advanced non-oat-cell lung cancer.
Tumori 1982;68(6):527-30.